Let’s start up with the current stock price of Zomedica Pharmaceuticals Corp. (ZOM), which is $0.17 to be very precise. The Stock rose vividly during the last session to $0.18 after opening rate of $0.18 while the lowest price it went was recorded $0.17 before closing at $0.17.
Recently in News on July 2, 2020, Zomedica Pharmaceuticals Corp. Announces $30 Million Public Offering. Zomedica Pharmaceuticals Corp. (NYSE American: ZOM), (“Zomedica” or the “Company”), a veterinary diagnostic company, today announced the pricing of its previously announced public offering of 187,500,000 common shares (or common share equivalents) of the Company, together with short-term warrants to purchase up to 187,500,000 common shares, at a combined public offering price of $0.16 per share and accompanying warrant. Each common share (or common share equivalent) is being sold in the offering together with one two-year warrant to purchase one common share at an exercise price of $0.16 per common share. There is no public trading market for the warrants, and Zomedica does not expect a market to develop. You can read further details here
Zomedica Pharmaceuticals Corp. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $0.4990 on 02/20/20, with the lowest value was $0.1100 for the same time period, recorded on 04/08/20.
Zomedica Pharmaceuticals Corp. (ZOM) full year performance was -31.20%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Zomedica Pharmaceuticals Corp. shares are logging -65.53% during the 52-week period from high price, and 56.36% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.11 and $0.50.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 68201296 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Zomedica Pharmaceuticals Corp. (ZOM) recorded performance in the market was -48.04%, having the revenues showcasing 5.13% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 72.08M, as it employees total of 28 workers.
Analysts verdict on Zomedica Pharmaceuticals Corp. (ZOM)
During the last month, 0 analysts gave the Zomedica Pharmaceuticals Corp. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 0.1946, with a change in the price was noted -0.0230. In a similar fashion, Zomedica Pharmaceuticals Corp. posted a movement of -11.79% for the period of last 100 days, recording 39,873,266 in trading volumes.
Zomedica Pharmaceuticals Corp. (ZOM): Technical Analysis
Raw Stochastic average of Zomedica Pharmaceuticals Corp. in the period of last 50 days is set at 13.35%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 14.20%. In the last 20 days, the company’s Stochastic %K was 11.97% and its Stochastic %D was recorded 27.07%.
Let’s take a glance in the erstwhile performances of Zomedica Pharmaceuticals Corp., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -48.04%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -48.21%, alongside a downfall of -31.20% for the period of the last 12 months. The shares increased approximately by -29.10% in the 7-day charts and went down by 1.24% in the period of the last 30 days. Common stock shares were driven by 5.13% during last recorded quarter.